Deciphering the host genetic factors conferring susceptibility to severe COVID-19 using exome sequencing

[1]  J. Olgin,et al.  A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection , 2023, Nature.

[2]  Matthew A. Wiles,et al.  GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 , 2023, Nature.

[3]  M. Kanai,et al.  Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity , 2023, Nature Genetics.

[4]  V. Rimoldi,et al.  Genetic susceptibility to severe COVID-19 , 2023, Infection, Genetics and Evolution.

[5]  L. Puig,et al.  Tyk2 Targeting in Immune-Mediated Inflammatory Diseases , 2023, International journal of molecular sciences.

[6]  William T. Harvey,et al.  SARS-CoV-2 variant biology: immune escape, transmission and fitness , 2023, Nature Reviews Microbiology.

[7]  H. Karabulut,et al.  Contribution of genotypes in Prothrombin and Factor V Leiden to COVID‐19 and disease severity in patients at high risk for hereditary thrombophilia , 2023, Journal of medical virology.

[8]  Huanming Yang,et al.  Towards precision medicine: Omics approach for COVID-19 , 2023, Biosafety and Health.

[9]  M. Bhattacharya,et al.  A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies , 2023, Viruses.

[10]  Benjamin Bowe,et al.  Acute and postacute sequelae associated with SARS-CoV-2 reinfection , 2022, Nature Medicine.

[11]  S. Jerônimo,et al.  Genome-wide association studies of COVID-19: Connecting the dots , 2022, Infection, Genetics and Evolution.

[12]  M. Buti,et al.  Detailed stratified GWAS analysis for severe COVID-19 in four European populations , 2022, Human Molecular Genetics.

[13]  S. Temel,et al.  Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS‐CoV‐2 from 946 whole‐exome sequencing data in the Turkish population , 2022, Journal of medical virology.

[14]  J. Casanova,et al.  Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee , 2022, Journal of Clinical Immunology.

[15]  J. Casanova,et al.  Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia , 2022, The Journal of experimental medicine.

[16]  C. Li,et al.  A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action , 2022, Molecular Psychiatry.

[17]  M. Jaeger,et al.  The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses , 2022, Frontiers in Immunology.

[18]  D. Altmann,et al.  COVID-19 vaccination: The road ahead , 2022, Science.

[19]  Jin-Jin Zhang,et al.  Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality , 2022, Clinical Reviews in Allergy & Immunology.

[20]  M. Netea,et al.  A guide to immunotherapy for COVID-19 , 2022, Nature Medicine.

[21]  Aidan N. Gomez,et al.  Disease variant prediction with deep generative models of evolutionary data , 2021, Nature.

[22]  Shobi Veleri.  Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients , 2021, Experimental brain research.

[23]  M. Farzan,et al.  Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.

[24]  T. Beccari,et al.  COVID-19 vaccine candidates and vaccine development platforms available worldwide , 2021, Journal of Pharmaceutical Analysis.

[25]  R. Miceli,et al.  Severe COVID-19 in Hospitalized Carriers of Single CFTR Pathogenic Variants , 2021, Journal of personalized medicine.

[26]  Mattia G. Bergomi,et al.  Mapping the human genetic architecture of COVID-19 , 2021, Nature.

[27]  A. Maghazachi,et al.  Chemokines and chemokine receptors during COVID-19 infection , 2021, Computational and Structural Biotechnology Journal.

[28]  A. Nakhaee,et al.  Significant association of LXRβ (NR1H2) polymorphisms (rs28514894, rs2303044) with type 2 diabetes mellitus and laboratory characteristics , 2021, Journal of Diabetes & Metabolic Disorders.

[29]  Christopher G Chute,et al.  The Human Phenotype Ontology in 2021 , 2020, Nucleic Acids Res..

[30]  C. Akdis,et al.  Risk factors for severe and critically ill COVID‐19 patients: A review , 2020, Allergy.

[31]  Barbara B. Shih,et al.  Genetic mechanisms of critical illness in COVID-19 , 2020, Nature.

[32]  Jacques Fellay,et al.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.

[33]  G. Musumeci,et al.  Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection , 2020, Experimental Cell Research.

[34]  J. Schuurs-Hoeijmakers,et al.  Presence of Genetic Variants Among Young Men With Severe COVID-19. , 2020, JAMA.

[35]  L. Álvarez-Vallina,et al.  Perforin gene variant A91V in young patients with severe COVID-19. , 2020, Haematologica.

[36]  T. Mogensen,et al.  Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19 , 2020, Frontiers in Immunology.

[37]  J. Casanova,et al.  Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity? , 2020, Nature Reviews Immunology.

[38]  S. Klein,et al.  Considering how biological sex impacts immune responses and COVID-19 outcomes , 2020, Nature Reviews Immunology.

[39]  Jacques Fellay,et al.  A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection , 2020, Cell.

[40]  N. Rezaei,et al.  Genetic predisposition models to COVID-19 infection , 2020, Medical Hypotheses.

[41]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[42]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[43]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[44]  Runan Yao,et al.  ShinyGO: a graphical gene-set enrichment tool for animals and plants , 2019, Bioinform..

[45]  Katherine R. Smith,et al.  PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels , 2019, Nature Genetics.

[46]  F. Corsolini,et al.  FAS‐mediated apoptosis impairment in patients with ALPS/ALPS‐like phenotype carrying variants on CASP10 gene , 2019, British journal of haematology.

[47]  J. Casanova,et al.  Severe influenza pneumonitis in children with inherited TLR3 deficiency , 2019, The Journal of experimental medicine.

[48]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[49]  M. Rovaris,et al.  HLA alleles modulate EBV viral load in multiple sclerosis , 2018, Journal of Translational Medicine.

[50]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[51]  E. Huang,et al.  Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis , 2015, Journal of Neuroimmunology.

[52]  Philippe Bardou,et al.  jvenn: an interactive Venn diagram viewer , 2014, BMC Bioinformatics.

[53]  Feng Liu,et al.  Defective activities, but not secretions, resulting from gene point mutations of human mannan-binding lectin , 2012, Molecular medicine reports.

[54]  Tomohiro Watanabe,et al.  NOD2, an Intracellular Innate Immune Sensor Involved in Host Defense and Crohn's Disease , 2011, Mucosal Immunology.

[55]  M. Carrington,et al.  Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. , 2011, The Journal of infectious diseases.

[56]  E. Alnemri,et al.  Involvement of the AIM2, NLRC4, and NLRP3 Inflammasomes in Caspase-1 Activation by Listeria monocytogenes , 2010, Journal of Clinical Immunology.

[57]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Mohammed A. Eid,et al.  Peer Review File Manuscript Title: Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19 Reviewer Comments & Author Rebuttals , 2022 .

[59]  I. Touitou,et al.  Autoinflammatory diseases. , 2008, Best practice & research. Clinical rheumatology.

[60]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .